132 related articles for article (PubMed ID: 21901249)
1. IKAROS isoform 6 enhances BCR-ABL1-mediated proliferation of human CD34+ hematopoietic cells on stromal cells.
Suzuki K; Ono R; Ohishi K; Masuya M; Kataoka I; Liu B; Nakamori Y; Ino K; Monma F; Hamada H; Kitamura T; Katayama N; Nosaka T
Int J Oncol; 2012 Jan; 40(1):53-62. PubMed ID: 21901249
[TBL] [Abstract][Full Text] [Related]
2. BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.
Klein F; Feldhahn N; Herzog S; Sprangers M; Mooster JL; Jumaa H; Müschen M
Oncogene; 2006 Feb; 25(7):1118-24. PubMed ID: 16205638
[TBL] [Abstract][Full Text] [Related]
3. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
[TBL] [Abstract][Full Text] [Related]
4. Expression of P190 and P210 BCR/ABL1 in normal human CD34(+) cells induces similar gene expression profiles and results in a STAT5-dependent expansion of the erythroid lineage.
Järås M; Johnels P; Agerstam H; Lassen C; Rissler M; Edén P; Cammenga J; Olofsson T; Bjerrum OW; Richter J; Fan X; Fioretos T
Exp Hematol; 2009 Mar; 37(3):367-75. PubMed ID: 19135771
[TBL] [Abstract][Full Text] [Related]
5. Dominant-negative IKAROS enhances IL-3-stimulated signaling in wild-type but not BCR-ABL1(+) mouse BA/F3 cells.
von Palffy S; Bulaeva E; Babovic S; Kannan N; Knapp DJ; Wei L; Eaves CJ; Beer PA
Exp Hematol; 2015 Jul; 43(7):514-23.e1-2. PubMed ID: 25951974
[TBL] [Abstract][Full Text] [Related]
6. Targeting of heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALL.
Lin X; Zou X; Wang Z; Fang Q; Chen S; Huang J; Zhe N; Yu M; Zhang Y; Wang J
Oncotarget; 2016 Aug; 7(33):53679-53701. PubMed ID: 27447561
[TBL] [Abstract][Full Text] [Related]
7. Forced expression of the Ikaros 6 isoform in human placental blood CD34(+) cells impairs their ability to differentiate toward the B-lymphoid lineage.
Tonnelle C; Bardin F; Maroc C; Imbert AM; Campa F; Dalloul A; Schmitt C; Chabannon C
Blood; 2001 Nov; 98(9):2673-80. PubMed ID: 11675337
[TBL] [Abstract][Full Text] [Related]
8. Effect of mutational inactivation of tyrosine kinase activity on BCR/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors.
Ramaraj P; Singh H; Niu N; Chu S; Holtz M; Yee JK; Bhatia R
Cancer Res; 2004 Aug; 64(15):5322-31. PubMed ID: 15289338
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow stromal cell line promotes the proliferation of mast cell progenitors derived from cord blood CD34+ cells under serum-free conditions with a combination of both cell-cell interaction and soluble factors.
Fujihara M; Azuma H; Ikeda H; Yamaguchi M; Hamada H
Artif Cells Blood Substit Immobil Biotechnol; 2011 Apr; 39(2):51-8. PubMed ID: 20626230
[TBL] [Abstract][Full Text] [Related]
10. Stage specific over-expression of the dominant negative Ikaros 6 reveals distinct role of Ikaros throughout human B-cell differentiation.
Tonnelle C; Dijon M; Moreau T; Garulli C; Bardin F; Chabannon C
Mol Immunol; 2009 May; 46(8-9):1736-43. PubMed ID: 19285729
[TBL] [Abstract][Full Text] [Related]
11. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
[TBL] [Abstract][Full Text] [Related]
12. Growth autonomy and lineage switching in BCR-ABL-transduced human cord blood cells depend on different functional domains of BCR-ABL.
Chalandon Y; Jiang X; Loutet S; Eaves AC; Eaves CJ
Leukemia; 2004 May; 18(5):1006-12. PubMed ID: 15014528
[TBL] [Abstract][Full Text] [Related]
13. Individual and combined effects of mesenchymal stromal cells and recombinant stimulatory cytokines on the in vitro growth of primitive hematopoietic cells from human umbilical cord blood.
Flores-Guzmán P; Flores-Figueroa E; Montesinos JJ; Martínez-Jaramillo G; Fernández-Sánchez V; Valencia-Plata I; Alarcón-Santos G; Mayani H
Cytotherapy; 2009; 11(7):886-96. PubMed ID: 19903101
[TBL] [Abstract][Full Text] [Related]
14. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia.
Castor A; Nilsson L; Astrand-Grundström I; Buitenhuis M; Ramirez C; Anderson K; Strömbeck B; Garwicz S; Békássy AN; Schmiegelow K; Lausen B; Hokland P; Lehmann S; Juliusson G; Johansson B; Jacobsen SE
Nat Med; 2005 Jun; 11(6):630-7. PubMed ID: 15908956
[TBL] [Abstract][Full Text] [Related]
15. Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells.
Coppo P; Dusanter-Fourt I; Millot G; Nogueira MM; Dugray A; Bonnet ML; Mitjavila-Garcia MT; Le Pesteur D; Guilhot F; Vainchenker W; Sainteny F; Turhan AG
Oncogene; 2003 Jun; 22(26):4102-10. PubMed ID: 12821944
[TBL] [Abstract][Full Text] [Related]
16. Illegitimate RAG-mediated recombination events are involved in IKZF1 Δ3-6 deletion in BCR-ABL1 lymphoblastic leukaemia.
Dong Y; Liu F; Wu C; Li S; Zhao X; Zhang P; Jiao J; Yu X; Ji Y; Zhang M
Clin Exp Immunol; 2016 Sep; 185(3):320-31. PubMed ID: 27198500
[TBL] [Abstract][Full Text] [Related]
17. Expression of Ikaros isoform 6 in chinese children with acute lymphoblastic leukemia.
Zhou F; Mei H; Jin R; Li X; Chen X
J Pediatr Hematol Oncol; 2011 Aug; 33(6):429-32. PubMed ID: 21792038
[TBL] [Abstract][Full Text] [Related]
18. p210BCR-ABL inhibits SDF-1 chemotactic response via alteration of CXCR4 signaling and down-regulation of CXCR4 expression.
Geay JF; Buet D; Zhang Y; Foudi A; Jarrier P; Berthebaud M; Turhan AG; Vainchenker W; Louache F
Cancer Res; 2005 Apr; 65(7):2676-83. PubMed ID: 15805265
[TBL] [Abstract][Full Text] [Related]
19. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
[TBL] [Abstract][Full Text] [Related]
20. A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells.
Beer PA; Knapp DJ; Kannan N; Miller PH; Babovic S; Bulaeva E; Aghaeepour N; Rabu G; Rostamirad S; Shih K; Wei L; Eaves CJ
Stem Cell Reports; 2014 Nov; 3(5):841-57. PubMed ID: 25418728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
